Students for Life of America (SFLA) President Kristan Hawkins is sending letters to the Department of Health and Human Services, the Food and Drug Administration (FDA), the Department of Justice (DOJ) and the Environmental Protection Agency.
In drafts shown exclusively to The Hill, Hawkins warned officials that the review will fail unless federal regulators conduct their own research and don’t look to previous studies, which have repeatedly found the drug to be safe and effective when taken as prescribed.
“Even if you wanted to accept past studies, Chemical Abortion Pills today are distributed on an unprecedent scale that conservatively results in more than 50 tons of chemically tainted blood, placenta tissue, and human remains being flushed into America’s waterways each year,” wrote Hawkins.
She asked to know who at the agencies will be conducting the review.
“Deep state agendas will likely taint the outcomes,” Hawkins warned.
The push follows a letter to red state attorneys general from top health officials promising a safety review of mifepristone, which has been on the market for 25 years.
In letters to Republicans attorneys general last week, Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said the agency would be reviewing mifepristone due to “recent studies raising concerns about the safety of mifepristone as currently administered.”
During the 2024 presidential campaign, the organization discussed two main issues with Trump officials; ending federal funding for Planned Parenthood and other abortion providers, and ending support and distribution of mifepristone.
